Count Me In: mapping clinical and genetic features of rare aggressive sarcomas in children and adults
Official title: Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
Funded at Broad Institute, INC. · NIH-11196726 · Data updated 2026-11-12
This project invites people with osteosarcoma or leiomyosarcoma to share their medical records and genetic samples so researchers can find new treatment targets and design better trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | September 1, 2020 |
| Project end | August 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $3,418,624 |
| NIH project number | 5U2CCA252974-06 |
| Project ID | NIH-11196726 on NIH RePORTER |
Who could benefit from this research
✓Could help
People of any age with a diagnosis of osteosarcoma or leiomyosarcoma who are willing to share medical records and, when possible, provide or allow access to tumor and normal tissue samples.
✕Less likely to help
People without osteosarcoma or leiomyosarcoma, or those unwilling or unable to provide consent, medical records, or samples, would not directly benefit from participation.
What this research studies
You can join the Osteosarcoma or Leiomyosarcoma Project online and give permission to share your health records, treatment history, and patient-reported experiences. The team will collect tumor and normal samples where possible and perform genomic and molecular testing to find underlying genetic changes. Your data will be combined with other participants' information in a shared database that researchers use to spot patterns and propose new therapies. Patients are treated as partners in designing the websites and consent process so your voice helps shape the project.
Why it matters
Potential benefit: If successful, this could speed up discovery of genetic drivers and lead to new targeted treatments, clinical trials, and better diagnostic tools for OS and LMS patients.
How similar studies have gone: Other patient-partnered genomic projects have successfully built large, useful datasets, but compiling comprehensive clinicogenomic data specifically for these rare sarcomas is a newer effort.
Where this research is happening
-
Broad Institute, INC.
Cambridge, United States Active
Researchers
- Principal investigator: Janeway, Katherine a — Broad Institute, INC.
- Study coordinator: Janeway, Katherine a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.